Hunting Viral Receptors Using Haploid Cells

Annual Review of Virology

Volumn 2, Issue , 2015, Pages 219-239

  Pillay, Sirika ^a   Carette, Jan E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ebola virus; Genetic screens; Lassa virus; Receptor identification; Virus entry

Indexed keywords

CELL SURFACE RECEPTOR; HOST FACTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; VIRUS RECEPTOR; PROTEIN BINDING; VIRAL PROTEIN;

BIOINFORMATICS; CORONAVIRIDAE; DELTA AGENT HEPATITIS; DNA LIBRARY; EBOLAVIRUS; ECHOVIRUS 6; ENTEROVIRUS B; GENETIC SCREENING; HAPLOIDY; HEPATITIS B; HEPATITIS C; HOST PATHOGEN INTERACTION; HUMAN ADENOVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INTERNALIZATION; LASSA VIRUS; MAMMAL CELL; MEASLES VIRUS; MICROARRAY ANALYSIS; NEW WORLD ARENAVIRUS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REOVIRIDAE; REVIEW; RHINOVIRUS; RNA INTERFERENCE; SARS CORONAVIRUS; SINDBIS VIRUS; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; ANIMAL; GENETICS; HUMAN; METABOLISM; VIROLOGY; VIRUS; VIRUS INFECTION;

ANIMALS; HAPLOIDY; HUMANS; PROTEIN BINDING; RECEPTORS, VIRUS; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 84969257208     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-100114-055119     Document Type: Review

References (123)

1. Demogines A, Abraham J, Choe H, Farzan M, Sawyer SL. 2013. Dual host-virus arms races shape an essential housekeeping protein. PLOS Biol. 11:e1001571
2. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, et al. 2007. Genome-wide detection and characterization of positive selection in human populations. Nature 449:913-18
3. Liu R, Paxton WA,Choe S,CeradiniD,Martin SR, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77
4. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearingmutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-25
5. Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. 1990. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell 63:353-62
6. Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, et al. 2013. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501:237-41
7. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-54
8. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, et al. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251-54
9. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, et al. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96
10. Li F. 2013. Receptor recognition and cross-species infections of SARS coronavirus. Antivir. Res. 100:246-54
11. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-20
12. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF,Weiss RA. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-67
13. KlatzmannD, Champagne E, Chamaret S, Gruest J, GuetardD, et al. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-68
14. Colonno RJ, Callahan PL, Long WJ. 1986. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J. Virol. 57:7-12
15. Palmenberg AC, Spiro D, Kuzmickas R, Wang S, Djikeng A, et al. 2009. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324:55-59
16. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, et al. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-47
17. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. 1989. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56:849-53
18. Haywood AM. 1994. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J. Virol. 68:1-5
19. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, et al. 1998. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-81
20. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17:1132-35
21. Mendelsohn CL,Wimmer E, Racaniello VR. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-65
22. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, et al. 1998. Binding of hepatitis C virus to CD81. Science 282:938-41
23. Petracca R, Falugi F, Galli G, Norais N, Rosa D, et al. 2000. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74:4824-30
24. Allander T, Forns X, Emerson SU, Purcell RH, Bukh J. 2000. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virology 277:358-67
25. Meola A, Sbardellati A, Bruni Ercole B, Cerretani M, Pezzanera M, et al. 2000. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J. Virol. 74:5933-38
26. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, et al. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21:5017-25
27. Dao Thi VL, Granier C, Zeisel MB, Guerin M, Mancip J, et al. 2012. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J. Biol. Chem. 287:31242-57
28. Sharma NR, MateuG,Dreux M, Grakoui A, Cosset FL, MelikyanGB. 2011. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J. Biol. Chem. 286:30361-76
29. Brazzoli M, Bianchi A, Filippini S, Weiner A, Zhu Q, et al. 2008. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J. Virol. 82:8316-29
30. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-5
31. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-86
32. Martin DN, Uprichard SL. 2013. Identification of transferrin receptor 1 as a hepatitis C virus entry factor. PNAS 110:10777-82
33. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, et al. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17:589-95
34. Lindenbach BD, Rice CM. 2013. The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. Microbiol. 11:688-700
35. Ploss A, Evans MJ. 2012. Hepatitis C virus host cell entry. Curr. Opin. Virol. 2:14-19
36. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-51
37. Tatsuo H, Ono N, Tanaka K, Yanagi Y. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-97
38. Muhlebach MD,Mateo M, Sinn PL, Prufer S,Uhlig KM, et al. 2011. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480:530-33
39. Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, et al. 2011. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLOS Pathog. 7:e1002240
40. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, et al. 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. PNAS 108:8426-31
41. Goff SP. 2008. Knockdown screens to knockout HIV-1. Cell 135:417-20
42. Rose PP, Hanna SL, Spiridigliozzi A, Wannissorn N, Beiting DP, et al. 2011. Natural resistanceassociated macrophage protein is a cellular receptor for Sindbis virus in both insect and mammalian hosts. Cell Host Microbe 10:97-104
43. Cherry S. 2009. What have RNAi screens taught us about viral-host interactions? Curr. Opin. Microbiol. 12:446-52
44. Kaelin WG Jr. 2012. Use and abuse of RNAi to study mammalian gene function. Science 337:421-22
45. Sledz CA, HolkoM, de Veer MJ, Silverman RH, Williams BR. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-39
46. Nagy PD, Pogany J, Lin JY. 2014. How yeast can be used as a genetic platform to explore virus-host interactions: from 'omics' to functional studies. Trends Microbiol. 22:309-16
47. JandaM, Ahlquist P. 1993. RNA-dependent replication, transcription, and persistence of brome mosaic virus RNA replicons in S. Cerevisiae. Cell 72:961-70
48. Kushner DB, Lindenbach BD, Grdzelishvili VZ, Noueiry AO, Paul SM, Ahlquist P. 2003. Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus. PNAS 100:15764-69
49. Diez J, Ishikawa M, Kaido M, Ahlquist P. 2000. Identification and characterization of a host protein required for efficient template selection in viral RNA replication. PNAS 97:3913-18
50. Noueiry AO, Diez J, Falk SP,Chen J, Ahlquist P. 2003. YeastLsm1p-7p/Pat1p deadenylation-dependent mRNA-decapping factors are required for brome mosaic virus genomic RNA translation. Mol. Cell. Biol. 23:4094-106
51. LeeWM, IshikawaM, Ahlquist P. 2001. Mutation of host-9 fatty acid desaturase inhibits bromemosaic virus RNA replication between template recognition and RNA synthesis. J. Virol. 75:2097-106
52. Panavas T, Serviene E, Brasher J, Nagy PD. 2005. Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses. PNAS 102:7326-31
53. Hao L, Lindenbach B, Wang X, Dye B, Kushner D, et al. 2014. Genome-wide analysis of host factors in nodavirus RNA replication. PLOS ONE 9:e95799
54. Guo G, Wang W, Bradley A. 2004. Mismatch repair genes identified using genetic screens in Blmdeficient embryonic stem cells. Nature 429:891-95
55. Andersson BS, Collins VP, Kurzrock R, Larkin DW, Childs C, et al. 1995. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Leukemia 9:2100-8
56. Kotecki M, Reddy PS, Cochran BH. 1999. Isolation and characterization of a near-haploid human cell line. Exp. Cell Res. 252:273-80
57. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76
58. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, et al. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477:340-43
59. Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, et al. 2014. Lassa virus entry requires a trigger-induced receptor switch. Science 344:1506-10
60. Essletzbichler P, Konopka T, Santoro F, Chen D, Gapp BV, et al. 2014. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line. Genome Res. 24:2059-65
61. Cong L, Ran FA, CoxD,Lin S, Barretto R, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-23
62. Mali P, Yang L, Esvelt KM, Aach J, Guell M, et al. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-26
63. Elling U, Taubenschmid J, Wirnsberger G, O'Malley R, Demers SP, et al. 2011. Forward and reverse genetics through derivation of haploid mouse embryonic stem cells. Cell Stem Cell 9:563-74
64. Leeb M, Wutz A. 2011. Derivation of haploid embryonic stem cells from mouse embryos. Nature 479:131-34
65. Leeb M, Walker R, Mansfield B, Nichols J, Smith A, Wutz A. 2012. Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development 139:3301-5
66. Li W, Shuai L, Wan H, Dong M, Wang M, et al. 2012. Androgenetic haploid embryonic stem cells produce live transgenic mice. Nature 490:407-11
67. Yang H, Shi L, Wang BA, Liang D, Zhong C, et al. 2012. Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell 149:605-17
68. Li W, Li X, Li T, JiangMG, WanH, et al. 2014. Geneticmodification and screening in rat using haploid embryonic stem cells. Cell Stem Cell 14:404-14
69. Yang H, Liu Z, Ma Y, Zhong C, Yin Q, et al. 2013. Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes. Cell Res. 23:1187-200
70. Birsoy K, Wang T, Possemato R, Yilmaz OH, Koch CE, et al. 2013. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat. Genet. 45:104-8
71. Pettitt SJ, Rehman FL, Bajrami I, Brough R, Wallberg F, et al. 2013. A genetic screen using the piggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity. PLOS ONE 8:e61520
72. Carette JE, Guimaraes CP, Varadarajan M, Park AS,Wuethrich I, et al. 2009. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326:1231-35
73. Carette JE,Guimaraes CP,Wuethrich I, Blomen VA, Varadarajan M, et al. 2011. Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat. Biotechnol. 29:542-46
74. LaFave MC, Varshney GK, Gildea DE,Wolfsberg TG, Baxevanis AD, Burgess SM. 2014. MLV integration site selection is driven by strong enhancers and active promoters. Nucleic Acids Res. 42:4257-69
75. Pettitt SJ, Tan EP, Yusa K. 2015. piggyBac transposon-based insertional mutagenesis in mouse haploid embryonic stem cells. Methods Mol. Biol. 1239:15-28
76. Tokunaga M, Kokubu C, Maeda Y, Sese J, Horie K, et al. 2014. Simulation and estimation of gene number in a biological pathway using almost complete saturation mutagenesis screening of haploid mouse cells. BMC Genomics 15:1016
77. Duncan LM, Timms RT, Zavodszky E, Cano F, Dougan G, et al. 2012. Fluorescence-based phenotypic selection allows forward genetic screens in haploid human cells. PLOS ONE 7:e39651
78. Liu S, Milne GT, Kuremsky JG, Fink GR, Leppla SH. 2004. Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2. Mol. Cell. Biol. 24:9487-97
79. Lin Z, Su X, ChenW, Ci B, Zhang S, LinH. 2014. Dph7 catalyzes a previously unknown demethylation step in diphthamide biosynthesis. J. Am. Chem. Soc. 136:6179-82
80. Schaffrath R, Abdel-FattahW, Klassen R, Stark MJ. 2014. The diphthamide modification pathway from Saccharomyces cerevisiae-revisited. Mol. Microbiol. 94:1213-26
81. Uthman S, Bar C, Scheidt V, Liu S, ten Have S, et al. 2013. The amidation step of diphthamide biosynthesis in yeast requires DPH6, a gene identified through mining the DPH1-DPH5 interaction network. PLOS Genet. 9:e1003334
82. Papatheodorou P, Carette JE, Bell GW, Schwan C, Guttenberg G, et al. 2011. Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). PNAS 108:16422-27
83. Papatheodorou P, Wilczek C, Nolke T, Guttenberg G, Hornuss D, et al. 2012. Identification of the cellular receptor of Clostridium spiroforme toxin. Infect. Immun. 80:1418-23
84. Schorch B, Song S, van Diemen FR, Bock HH, May P, et al. 2014. LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins. PNAS 111:6431-36
85. Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Moller P, et al. 2004. Properties of replicationcompetent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol. 78:5458-65
86. Lawson ND, Stillman EA, Whitt MA, Rose JK. 1995. Recombinant vesicular stomatitis viruses from DNA. PNAS 92:4477-81
87. Schnell MJ, Buonocore L, Whitt MA, Rose JK. 1996. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:2318-23
88. Whelan SP, Ball LA, Barr JN, WertzGT. 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. PNAS 92:8388-92
89. Geisbert TW, Feldmann H. 2011. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 204(Suppl. 3):S1075-81
90. Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. 2010. Identification of the switch in early-to-late endosome transition. Cell 141:497-508
91. Mingo RM, Simmons JA, Shoemaker CJ, Nelson EA, Schornberg KL, et al. 2015. Ebola and SARS display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J. Virol. 89:2931-43
92. Cote M, Misasi J, Ren T, Bruchez A, Lee K, et al. 2011. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477:344-48
93. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, et al. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31:1947-60
94. Ng M, Ndungo E, Jangra RK, Cai Y, Postnikova E, et al. 2014. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology 468-70:637-46
95. Lukashevich IS,MaryankovaRF, Fidarov FM. 1983. Reproduction of Lassa virus in different cell cultures. Acta Virol. 27:282-85
96. Rohrer J, SchweizerA,Russell D, Kornfeld S. 1996. The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. J. Cell Biol. 132:565-76
97. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, et al. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 340:479-83
98. Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, et al. 2013. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science 341:896-99
99. Petersen J, DrakeMJ, Bruce EA, Riblett AM, Didigu CA, et al. 2014. Themajor cellular sterol regulatory pathway is required for Andes virus infection. PLOS Pathog. 10:e1003911
100. Lee JE, FuscoML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-82
101. ReynardO, Borowiak M, Volchkova VA,Delpeut S, MateoM,VolchkovVE. 2009. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J. Virol. 83:9596-601
102. Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P. 2010. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLOS Pathog. 6:e1001098
103. Misasi J, Sullivan NJ. 2014. Camouflage and misdirection: The full-on assault of Ebola virus disease. Cell 159:477-86
104. Sandvig K, van Deurs B. 2000. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J. 19:5943-50
105. Mukhopadhyay S, Linstedt AD. 2012. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335:332-35
106. WHO(World Health Organ.). 2015. Ebola situation report. May 6. http://apps.who.int/iris/bitstream/10665/164523/1/roadmapsitrep-6May15'eng.pdf
107. Bishop BM. 2015. Potential and emerging treatment options for Ebola virus disease. Ann. Pharmacother. 49:196-206
108. Lee K, Ren T, Cote M, Gholamreza B, Misasi J, et al. 2013. Inhibition of Ebola virus infection: identification of Niemann-Pick C1 as the target by optimization of a chemical probe. ACS Med. Chem. Lett. 4:239-43
109. Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, et al. 2013. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLOS ONE 8:e56265
110. Doudna JA, Charpentier E. 2014. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096
111. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262-78
112. Bergelson JM, Chan M, Solomon KR, St. John NF, Lin H, Finberg RW. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. PNAS 91:6245-48
113. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-23
114. Yan H, Zhong G, Xu G, He W, Jing Z, et al. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049
115. Timms RT, Duncan LM, Tchasovnikarova IA, Antrobus R, Smith DL, et al. 2013. Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases. PLOS Pathog. 9:e1003772
116. Guimaraes CP, Carette JE, Varadarajan M, Antos J, Popp MW, et al. 2011. Identification of host cell factors required for intoxication through use of modified cholera toxin. J. Cell Biol. 195:751-64
117. RosmarinDM, Carette JE,Olive AJ, Starnbach MN, Brummelkamp TR, Ploegh HL. 2012. Attachment of Chlamydia trachomatis L2 to host cells requires sulfation. PNAS 109:10059-64
118. Winter GE, Radic B, Mayor-Ruiz C, Blomen VA, Trefzer C, et al. 2014. The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity. Nat. Chem. Biol. 10:768-73
119. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, et al. 2014. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56:481-95
120. Lee CC, Carette JE, Brummelkamp TR, Ploegh HL. 2013. A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κB. PLOS ONE 8:e70339
121. Reiling JH, Olive AJ, Sanyal S, Carette JE, Brummelkamp TR, et al. 2013. A CREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens. Nat. Cell Biol. 15:1473-85
122. Reiling JH, Clish CB, Carette JE, Varadarajan M, Brummelkamp TR, Sabatini DM. 2011. A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. PNAS 108:11756-65
123. Leeb M, Dietmann S, Paramor M, Niwa H, Smith A. 2014. Genetic exploration of the exit from selfrenewal using haploid embryonic stem cells. Cell Stem Cell 14:385-93